Katsuyuki Iida

发表

Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder Carcinogenesis

H. Akaza, K. Itoh, Masayuki Yamamoto, 2004, Cancer Research.

Chemopreventive effects of cyclooxygenase‐2 inhibitor and epidermal growth factor‐receptor kinase inhibitor on rat urinary bladder carcinogenesis

H. Akaza, R. Oyasu, K. Hattori, 2006, BJU international.

A Sulforaphane Analogue That Potently Activates the Nrf2-dependent Detoxification Pathway*

K. Itoh, Masayuki Yamamoto, Yoshimasa Nakamura, 2002, The Journal of Biological Chemistry.

Neutral endopeptidase is a myristoylated protein

A. Horiguchi, D. Nanus, O. Goodman, 2010, Molecular and Cellular Biochemistry.

Rational redesign of neutral endopeptidase binding to merlin and moesin proteins

M. Niv, A. Horiguchi, D. Nanus, 2009, Protein science : a publication of the Protein Society.

Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer

D. Nanus, R. Shen, Rong Zheng, 2012, International journal of oncology.

Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.

H. Akaza, K. Itoh, Masayuki Yamamoto, 2007, Carcinogenesis.

Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice.

Y. Fujii‐Kuriyama, H. Akaza, K. Itoh, 2010, Journal of biochemistry.

Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome.

Ken Itoh, Masayuki Yamamoto, Yasutake Katoh, 2005, Archives of biochemistry and biophysics.